Agenda & Learning Objectives

Participants in this program will:
  • Explore the relationship between gut inflammation and mental health disorders
  • Consider resiliency and mental health in the IBD patient
  • Explore the concepts of core inflammatory pathways/cytokine hubs in immune-mediated diseases
  • Discuss the division of leukocytes into inflammatory versus anti-inflammatory roles in the gut and consider cell therapy
  • Integrate basic science and clinical practice by participating in a choice of workshops to:
    • Learn the secrets for academic success from Canadian investigators
    • Develop strategies to keep up-to-date on the latest IBD literature
    • Discuss progress towards precision health in IBD
    • Examine treatment options for mental health in IBD
  • Discuss what makes the gut abnormally inflamed
  • Explore treatment approaches to the microbiome

NOTE: Junior Investigator Award – Please go to the Call for Abstracts page on the registration site
 

Time Title/Topic Speakers
8:30

0.1 Welcome 
Nurse of the Year Award, Physician of the Year Award, CCC-Pfizer Women in IBD Emerging Researcher Award, CCC-Pfizer Women in IBD Outstanding Researcher Award

Lori Radke
CEO, Crohn's and Colitis Canada
8:40 0.2 Opening Remarks – Welcome, program objectives 
CO-CHAIRS:
Remo Panaccione & Hillary Steinhart

Session I: The Brain-Gut Axis in Mental Health

SESSION CHAIR:
Charles Bernstein
8:50 1.1 Plenary Presentation
Gut Inflammation and Mental Health: The missing link?
Valerie Taylor,
University of Calgary
9:10 1.2 Plenary Presentation
Resiliency and Mental Health: A key to success? 
Leslie Graff,
University of Manitoba
9:30 1.3 Ask-the Expert Panel Session SESSION CHAIR: Charles Bernstein
PANEL: Lesley Graff, Jennifer Jones,
Valerie Taylor
9:50
1.5 Junior Investigator Award & Presentation
TBA
10:15 Refreshment Break (15 minutes)  

Session II: New Agents -  Immunity and Inflammation

SESSION CHAIR:
Andrew Stadnyk
10:30 2.1 Plenary Presentation
Inflammatory pathways in immune-mediated diseases: What is downstream?
Raja Atreya,
University Hospital Erlangen,
Germany

 
10:50 2.2 Plenary Presentation
New Cell Pathways for Understanding IBD
Megan Levings,
University of British Columbia
11:10 2.3 Ask-the Expert Panel Session SESSION CHAIR: Andrew Stadnyk
PANEL: Raja Atreya, Kenneth Croitoru,
Megan Levings

 
11:30 2.4 Rising Star Award & Presentation TBA
11:50 Lunch Break (60 minutes)  

Session III: Workshops – Hot Topics from Bench to Policy

12:50 Placement into Workshops  
12:55 3.1 Workshop
Road to Academic Success: Grant writing and publishing
Gilaad Kaplan & Amanda Ricciuto
3.2 Workshop
The Mountain of Scientific Literature: How do we stay on top?
Eric Benchimol & Vivian Huang
3.3 Workshop
Precision Health in IBD: What’s on the horizon?
Raja Atreya & Megan Levings
3.4 Workshop
Mental Health and its Impact on IBD Care: Challenges for patients and clinicians
Jon Hunter & Robert Maunder
13:40 Grab and Go Break (5 minutes)  

Session IV: Manipulating the Microbiome: Novel Approaches 

SESSION CHAIR:
Dina Kao
13:45 4.0 Research Leadership Award & Presentation TBA
14:05 4.1 Plenary Presentation
The Microbiome in IBD: What makes the gut abnormally inflamed?
Michael Surette,
McMaster University
14:25 4.2 Plenary Presentation
Altering the Microbiota in Clinical Practice: What’s worth trying?
Eytan Wine, 
University of Alberta
14:45 4.3 Ask-the Expert Panel Session SESSION CHAIR: Dina Kao
PANEL: Neeraj Narula,
Maitreyi Raman, Michael Surette
Eytan Wine
15:05 Closing Remarks and Program Evaluation CO-CHAIRS: 
Remo Panaccione & Hillary Steinhart

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.